Pulmonary papillary adenoma with malignant transformation: report of one case and review of the literature.
C-myc
FDG
Pulmonary
cancer development
papillary adenoma
Journal
International journal of clinical and experimental pathology
ISSN: 1936-2625
Titre abrégé: Int J Clin Exp Pathol
Pays: United States
ID NLM: 101480565
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
01
2020
accepted:
06
03
2020
entrez:
2
5
2020
pubmed:
2
5
2020
medline:
2
5
2020
Statut:
epublish
Résumé
Pulmonary papillary adenoma is a rare tumor. A total of 32 cases was studied, include 31 cases in the literature. Most of the patients were asymptomatic, and tumor was usually discovered during a routine chest roentgenogram or with other disease. Most cases demonstrated benign behavior and there have been no recurrent cases after the operation or biopsy with the follow up of 6 to 120 months. However, there was some evidence indicating it can be locally aggressive or potentially malignant. We present the first case report of cancer development in a pulmonary papillary adenoma. In our case, the imaging findings progressed from initial well-defined border, without 18F-FDG accumulation, to one side rough edge after two years of follow up. Postoperative pathology revealed a partly well-defined tumor, without a fibrous capsule, but focally infiltrated the alveoli. Our case had definite areas of papillary adenoma, with focal acinar and micropapillary adenocarcinoma area near the central fibrosis. The papillary adenoma cells were with polarity and low expression of Ki67 and C-myc, without atypia or mitosis. But the adenocarcinoma cells were obviously different from them, with high expression of Ki67 and C-myc, indicating cancer development. MYC activation may play a role in tumorigenesis, and further investigation was needed. There was no EGFR mutation in both of the components.
Types de publication
Case Reports
Langues
eng
Pagination
792-798Informations de copyright
IJCEP Copyright © 2020.
Déclaration de conflit d'intérêts
None.
Références
Diagn Pathol. 2015 Oct 17;10:190
pubmed: 26474555
Pediatr Pulmonol. 1994 Jun;17(6):396-400
pubmed: 8090612
Virchows Arch. 2000 Mar;436(3):289-95
pubmed: 10782889
Respiration. 1993;60(6):373-7
pubmed: 8290804
Med Pediatr Oncol. 2002 Feb;38(2):125-7
pubmed: 11813181
Acta Cytol. 2004 Mar-Apr;48(2):243-8
pubmed: 15085761
Gen Thorac Cardiovasc Surg. 2010 Oct;58(10):542-5
pubmed: 20941571
Am J Surg Pathol. 1986 Feb;10(2):134-9
pubmed: 3006525
Diagn Cytopathol. 2016 Jun;44(6):543-7
pubmed: 27040894
Virchows Arch. 1996 Jun;428(3):195-200
pubmed: 8688974
Pneumologie. 2007 Nov;61(11):697-9
pubmed: 17886196
Pathol Int. 2012 Sep;62(9):640-5
pubmed: 22924850
Arch Pathol Lab Med. 1991 Aug;115(8):797-801
pubmed: 1863190
Cancer. 1980 Mar 15;45(6):1486-97
pubmed: 7357529
Pathol Int. 2011 Aug;61(8):475-80
pubmed: 21790862
Pathol Int. 2013 Jul;63(7):364-7
pubmed: 23865575
Acta Pathol Jpn. 1992 Jan;42(1):56-61
pubmed: 1557989
Cancer. 1982 Dec 15;50(12):2839-44
pubmed: 7139574
J Coll Physicians Surg Pak. 2017 Sep;27(9):582-583
pubmed: 29017679
J Bronchology Interv Pulmonol. 2013 Jan;20(1):52-7
pubmed: 23328145
Pneumologie. 2011 Jul;65(7):406-11
pubmed: 21512974
Histopathology. 2003 Oct;43(4):404-5
pubmed: 14511264
Korean J Pathol. 2014 Feb;48(1):66-8
pubmed: 24627699
Am J Clin Pathol. 1992 Mar;97(3):393-7
pubmed: 1543163
Pol J Pathol. 2009;60(1):49-51
pubmed: 19670704